These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37627742)

  • 41. Moving forward in tackling antimicrobial resistance: WHO actions.
    Lusti-Narasimhan M; Pessoa-Silva CL; Temmerman M
    Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv57-9. PubMed ID: 24202206
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outcomes and Future Prospect of Japan's National Action Plan on Antimicrobial Resistance (2016-2020).
    Gu Y; Fujitomo Y; Ohmagari N
    Antibiotics (Basel); 2021 Oct; 10(11):. PubMed ID: 34827231
    [TBL] [Abstract][Full Text] [Related]  

  • 43. India's National Action Plan on Antimicrobial Resistance: a critical perspective.
    Nair M; Zeegers MP; Varghese GM; Burza S
    J Glob Antimicrob Resist; 2021 Dec; 27():236-238. PubMed ID: 34695609
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The strategic plan for combating antimicrobial resistance in Gulf Cooperation Council States.
    Balkhy HH; Assiri AM; Mousa HA; Al-Abri SS; Al-Katheeri H; Alansari H; Abdulrazzaq NM; Aidara-Kane A; Pittet D;
    J Infect Public Health; 2016; 9(4):375-85. PubMed ID: 27106389
    [TBL] [Abstract][Full Text] [Related]  

  • 45. One Health Surveillance of Antimicrobial Use and Resistance: Challenges and Successes of Implementing Surveillance Programs in Sri Lanka.
    Ariyawansa S; Gunawardana KN; Hapudeniya MM; Manelgamage NJ; Karunarathne CR; Madalagama RP; Ubeyratne KH; Wickramasinghe D; Tun HM; Wu P; Lam TTY; Chan OSK
    Antibiotics (Basel); 2023 Feb; 12(3):. PubMed ID: 36978313
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The governance of antimicrobial resistance in Brazil: Challenges for developing and implementing a one health agenda.
    Corrêa JS; Zago LF; Da Silva-Brandão RR; de Oliveira SM; Fracolli LA; Padoveze MC; Cordoba G
    Glob Public Health; 2023 Jan; 18(1):2190381. PubMed ID: 36934430
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The challenges of investigating antimicrobial resistance in Vietnam - what benefits does a One Health approach offer the animal and human health sectors?
    Mitchell MEV; Alders R; Unger F; Nguyen-Viet H; Le TTH; Toribio JA
    BMC Public Health; 2020 Feb; 20(1):213. PubMed ID: 32046713
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Addressing gaps in AMR awareness in the public: an evidence-based policy brief to guide school curriculum review in Uganda.
    Waswa JP; Kiggundu R; Joshi MP; Mpagi J; Kasujja H; Murungi M; Kajumbula H; Were E; Schwarz D; Lwere K; Konduri N
    Front Public Health; 2023; 11():1287523. PubMed ID: 38074735
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A review of national action plans on antimicrobial resistance: strengths and weaknesses.
    Willemsen A; Reid S; Assefa Y
    Antimicrob Resist Infect Control; 2022 Jun; 11(1):90. PubMed ID: 35739564
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The urban political ecology of antimicrobial resistance: A critical lens on integrative governance.
    Aguiar R; Keil R; Wiktorowicz M
    Soc Sci Med; 2024 May; 348():116689. PubMed ID: 38564956
    [TBL] [Abstract][Full Text] [Related]  

  • 51. National action to combat AMR: a One-Health approach to assess policy priorities in action plans.
    Ogyu A; Chan O; Littmann J; Pang HH; Lining X; Liu P; Matsunaga N; Ohmagari N; Fukuda K; Wernli D
    BMJ Glob Health; 2020 Jul; 5(7):. PubMed ID: 32665430
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of a cross-sectoral antimicrobial resistance capability assessment framework.
    Ferdinand AS; McEwan C; Lin C; Betham K; Kandan K; Tamolsaian G; Pugeva B; McKenzie J; Browning G; Gilkerson J; Coppo M; James R; Peel T; Levy S; Townell N; Jenney A; Stewardson A; Cameron D; Macintyre A; Buising K; Howden BP
    BMJ Glob Health; 2024 Jan; 9(1):. PubMed ID: 38232993
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Population knowledge and awareness of antibiotic use and antimicrobial resistance: results from national household survey 2019 and changes from 2017.
    Tangcharoensathien V; Chanvatik S; Kosiyaporn H; Kirivan S; Kaewkhankhaeng W; Thunyahan A; Lekagul A
    BMC Public Health; 2021 Nov; 21(1):2188. PubMed ID: 34844593
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Control of antimicrobial resistance in Iran: the role of international factors.
    Mehtarpour M; Takian A; Eshrati B; Jaafaripooyan E
    BMC Public Health; 2020 Jun; 20(1):873. PubMed ID: 32503497
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Progress of Global Antimicrobial Resistance Governance and Its Implication to China: A Review.
    Yin J; Wang Y; Xu X; Liu Y; Yao L; Sun Q
    Antibiotics (Basel); 2021 Nov; 10(11):. PubMed ID: 34827294
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Knowing antmicrobial resistance in practice: a multi-country qualitative study with human and animal healthcare professionals.
    Pearson M; Chandler C
    Glob Health Action; 2019; 12(1):1599560. PubMed ID: 31294679
    [No Abstract]   [Full Text] [Related]  

  • 57. Leveraging donor support to develop a national antimicrobial resistance policy and action plan: Ghana's success story.
    Opintan JA
    Afr J Lab Med; 2018; 7(2):825. PubMed ID: 30568905
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antimicrobial resistance as a super wicked problem: how do we engage the public to be part of the solution.
    Rickard H; Watkin S; Baldwin N; De Souza A; Ciric L; Cloutman-Green E
    Infect Prev Pract; 2023 Dec; 5(4):100314. PubMed ID: 38107239
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Control of antimicrobial resistance in Cameroon: Feasibility of implementing the National Action Plan.
    Amin ET; Omeichu AA; Shu DM; Ekome SRE; Njumkeng C; van der Sande MAB
    Trop Med Int Health; 2021 Oct; 26(10):1231-1239. PubMed ID: 34218501
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Public perception and community-level impact of national action plans on antimicrobial resistance in Vietnam.
    Thomas SA; Mathew P; Ranjalkar J; Nguyen TBV; Giao VTQ; Chandy SJ
    JAC Antimicrob Resist; 2024 Feb; 6(1):dlad146. PubMed ID: 38161968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.